➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Medtronic
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Vatalanib

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Vatalanib?

Vatalanib is an investigational drug.

There have been 23 clinical trials for Vatalanib. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2003.

The most common disease conditions in clinical trials are Central Nervous System Neoplasms, Carcinoid Tumor, and Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Novartis, and Bayer.

Recent Clinical Trials for Vatalanib
TitleSponsorPhase
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric CancerThe Affiliated Hospital of the Chinese Academy of Military Medical SciencesPhase 1/Phase 2
Apatinib for Metastatic Esophageal Cancer.Hangzhou Cancer HospitalPhase 2
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1

See all Vatalanib clinical trials

Clinical Trial Summary for Vatalanib

Top disease conditions for Vatalanib
Top clinical trial sponsors for Vatalanib

See all Vatalanib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Medtronic
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.